AcelRx Pharmaceuticals (ACRX) Stock: Diving On Offering News

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is tanking heavily in the pre-market hours today, and for good reason. The company announced minutes ago that it plans on moving forward with a public offering. While this type of news generally leads to concern, the declines caused by today’s news may actually be an opportunity. Today, we’ll talk … Read more

AcelRx Pharmaceuticals (ACRX) Stock: The Dsuvia Approval Changes The Game

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) could see some very strong times ahead, and for good reason. While the company reported an earnings report that missed the mark on Friday, something else happened that made it so that investors weren’t concerned. The company received FDA approval for Dsuvia, an incredibly powerful pain killer. Today, we’ll talk … Read more

AcelRx Pharmaceuticals (ACRX) Stock: Here’s Why It’s Flying

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is having an incredibly strong start to the trading session this morning, but if you’re looking for press releases or SEC filings, you’re not going to find anything issued today. Nonetheless, we believe that we know the reason for the gains. Today, we’ll talk about: Why ACRX stock is headed … Read more

AcelRx Pharmaceuticals (ACRX) Stock: Here’s What’s Happening!

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) has been all over the place this morning. Early in the pre-market, the stock was trading deep in the red. Right now, it’s slightly in the green. But with no press releases or SEC filings, many are wondering what’s going on. Today, we’ll talk about: Why ACRX is trading irradically; … Read more

AcelRx Pharmaceuticals (ACRX) Stock: Gaining On European Approval

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is having a great start to the trading session this morning, and for good reason. The company announced European approval of one of its treatments. Of course, the news proved to excite investors, sending the stock screaming for the top. Today, we’ll talk about: The approval; what we’re seeing from … Read more

AcelRx Pharmaceuticals Inc (ACRX) Stock: Headed Up On Private Share Acquisition

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is having an overwhelmingly strong start to the trading session this morning after the company announced that shares owned by Three Arch Partners have been acquired in a private deal. Of course, the news led to excitement among investors, sending the stock upward. Today, we’ll talk about: The share acquisition; … Read more

AcelRx Pharmaceuticals (ACRX) Stock: Falling Hard On FDA Rejection

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is having an overwhelmingly rough day in the market today, and for good reason. The United States Food and Drug Administration (FDA) has rejected the company’s painkilling drug. Of course, this is causing fear among investors, sending the stock spiraling down to the bottom. As is normally the case, our … Read more

AcelRx Pharmaceuticals (ACRX) Stock: Gaining Big On Coming Catalyst

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is having an incredibly strong day in the market today, and for good reason. A Seeking Alpha contributor wrote an article about the company, bringing a massive coming catalyst to light and causing excitement among investors. Of course, this led to gains in the stock, prompting our friends at Trade … Read more